{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:07:09Z","timestamp":1765728429567},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00520-011-1308-4","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T13:29:56Z","timestamp":1321450196000},"page":"2017-2024","source":"Crossref","is-referenced-by-count":18,"title":["Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients"],"prefix":"10.1007","volume":"20","author":[{"given":"H.","family":"Ishiguro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Toi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,16]]},"reference":[{"key":"1308_CR1","unstructured":"National Comprehensive Cancer Network (2011). NCCN clinical practice guidelines in oncology: myeloid growth factors, V.1. 2011. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/myeloid_growth.pdf . Accessed 9 May 2011"},{"issue":"19","key":"1308_CR2","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","volume":"24","author":"TJ Smith","year":"2006","unstructured":"Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24(19):3187\u20133205. doi: 10.1200\/JCO.2006.06.4451","journal-title":"J Clin Oncol"},{"key":"1308_CR3","unstructured":"National Comprehensive Cancer Network (2011). NCCN clinical practice guidelines in oncology: antiemesis, V.3.2011. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf . Accessed 9 May 2011"},{"issue":"18","key":"1308_CR4","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1200\/JCO.2006.06.9591","volume":"24","author":"MG Kris","year":"2006","unstructured":"Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24(18):2932\u20132947. doi: 10.1200\/JCO.2006.06.9591","journal-title":"J Clin Oncol"},{"issue":"2","key":"1308_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/annonc\/mdg050","volume":"14","author":"AM Minisini","year":"2003","unstructured":"Minisini AM, Tosti A, Sobrero AF, Mansutti M, Piraccini BM, Sacco C, Puglisi F (2003) Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 14(2):333\u2013337","journal-title":"Ann Oncol"},{"issue":"19","key":"1308_CR6","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","volume":"23","author":"F Scott\u00eb","year":"2005","unstructured":"Scott\u00eb F, Tourani JM, Banu E, Peyromaure M, Levy E, Marsan S, Magherini E, Fabre-Guillevin E, Andrieu JM, Oudard S (2005) Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol 23(19):4424\u20134429. doi: 10.1200\/JCO.2005.15.651","journal-title":"J Clin Oncol"},{"issue":"6","key":"1308_CR7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0959-8049(00)00012-5","volume":"36","author":"P Katsimbri","year":"2000","unstructured":"Katsimbri P, Bamias A, Pavlidis N (2000) Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 36(6):766\u2013771","journal-title":"Eur J Cancer"},{"issue":"2","key":"1308_CR8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0959-8049(96)00374-7","volume":"33","author":"M Lemenager","year":"1997","unstructured":"Lemenager M, Lecomte S, Bonneterre ME, Bessa E, Dauba J, Bonneterre J (1997) Effectiveness of cold cap in the prevention of docetaxel-induced alopecia. Eur J Cancer 33(2):297\u2013300","journal-title":"Eur J Cancer"},{"issue":"6","key":"1308_CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00520-003-0451-y","volume":"11","author":"M Ridderheim","year":"2003","unstructured":"Ridderheim M, Bjurberg M, Gustavsson A (2003) Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 11(6):371\u2013377. doi: 10.1007\/s00520-003-0451-y","journal-title":"Support Care Cancer"},{"issue":"3","key":"1308_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.1991.9.3.449","volume":"9","author":"DJ Mahood","year":"1991","unstructured":"Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL et al (1991) Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9(3):449\u2013452","journal-title":"J Clin Oncol"},{"key":"1308_CR11","unstructured":"Takashima S, Nakata K, Kameno K, Yonesaku N, Teramukai S, Yanagihara K, Ishiguro H (2006) Observational study of docetaxel-induced nail-related adverse event and modification of hand cooling method using frozen glove. J Jpn Soc Cancer Ther (41):907"},{"key":"1308_CR12","unstructured":"Taxotere (docetaxel) [package insert]. Paris, France: Sanofi Aventis."},{"issue":"31","key":"1308_CR13","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1200\/JCO.2005.05.0294","volume":"24","author":"V Harvey","year":"2006","unstructured":"Harvey V, Mouridsen H, Semiglazov V, Jakobsen E, Voznyi E, Robinson BA, Groult V, Murawsky M, Cold S (2006) Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer. J Clin Oncol 24(31):4963\u20134970. doi: 10.1200\/JCO.2005.05.0294","journal-title":"J Clin Oncol"},{"issue":"20","key":"1308_CR14","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1200\/JCO.2008.21.6457","volume":"28","author":"DW Miles","year":"2010","unstructured":"Miles DW, Chan A, Dirix LY, Cortes J, Pivot X, Tomczak P, Delozier T, Sohn JH, Provencher L, Puglisi F, Harbeck N, Steger GG, Schneeweiss A, Wardley AM, Chlistalla A, Romieu G (2010) Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. J Clin Oncol 28(20):3239\u20133247. doi: 10.1200\/JCO.2008.21.6457","journal-title":"J Clin Oncol"},{"key":"1308_CR15","volume-title":"Multicenter phase II study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity for the breast cancer patients (Kinki Multidisciplinary Breast Oncology Group: KMBOG-0605)","author":"M Sakurai","year":"2008","unstructured":"Sakurai M, Todaka K, Takada N, Kamigaki S, Anami S, Shikata A, Ueno H, Iseki C, Fujii C, Fujino M, Yamamura J, Masuda H, Ishitobi M, Nakayama T, Masuda N (2008) Multicenter phase II study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity for the breast cancer patients (Kinki Multidisciplinary Breast Oncology Group: KMBOG-0605). San Antonio Breast Cancer Symposium, San Antonio"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00520-011-1308-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T15:13:28Z","timestamp":1593270808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-011-1308-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,16]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1007\/s00520-011-1308-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,16]]}}}